Gene: TBXA2R
Official Full Name: thromboxane A2 receptorprovided by HGNC
Gene Summary: This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08063 | TBXA2R Knockout cell line (HeLa) | Human | TBXA2R | 1:3~1:6 | Negative | Online Inquiry |
KO08064 | TBXA2R Knockout cell line (HCT 116) | Human | TBXA2R | 1:2~1:4 | Negative | Online Inquiry |
KO08065 | TBXA2R Knockout cell line (HEK293) | Human | TBXA2R | 1:3~1:6 | Negative | Online Inquiry |
TBXA2R Gene Knockout Cell Lines are genetically engineered cell models specifically designed to lack the thromboxane A2 receptor (TBXA2R) gene. These cell lines are a pivotal tool for researchers seeking to understand the complex biological roles of TBXA2R, which is implicated in various physiological processes including platelet aggregation, vasoconstriction, and the regulation of blood pressure. By utilizing these knockout models, scientists can investigate the downstream signaling pathways and cellular responses that are mediated by this receptor, facilitating a deeper understanding of its contribution to cardiovascular diseases and other pathologies.
The key mechanism by which TBXA2R Gene Knockout Cell Lines operate involves the disruption of the TBXA2R gene, leading to a complete absence of the receptor on the cell surface. This allows for the examination of both direct and indirect consequences of TBXA2R signaling disruption. Researchers can utilize these cell lines to assess alterations in cell behavior, including changes in proliferation, apoptosis, and reaction to thromboxane A2, thereby providing critical insights into drug interactions, receptor functions, and potential therapeutic targets.
Scientifically, these knockout cell lines are invaluable in hypertension research, cardiovascular studies, and potential therapeutic interventions. They offer a model for simulating human disease conditions in vitro, supporting drug development and testing processes without reliance on animal models for initial screenings. Compared to traditional models, such as wild-type cell lines, the TBXA2R Gene Knockout Cell Lines provide specific accuracy and relevance in the context of TBXA2R research.
The advantages of using these specialized cell lines include higher fidelity in replicating disease states, reduced background signaling, and the facilitation of targeted therapeutic experiments, addressing the limitations often faced with more generalized cell models. This makes them particularly attractive to researchers focused on elucidating receptor physiology or screening pharmacological agents aimed at modulating TBXA2R activity.
Holding a strong emphasis on quality and innovation, our company specializes in providing advanced biological tools, including these TBXA2R Gene Knockout Cell Lines, underscoring our commitment to excellence in research support. With our expertise in genetic engineering and cell biology, we are dedicated to equipping laboratories with the best resources for advancing scientific discovery and improving clinical outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.